Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2023

Feb 14, 2023

29745_dirs_2023-02-14_bf53cd44-69d0-46e3-8190-dbb6cad56a36.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-02-10

Reporting Person: Jonsson Patrik (EVP&Pres, LLY Imm, LLY USA&CCO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-10 Common Stock A 7886 $345.12 Acquired 42941 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-10 Restricted Stock Unit $ A 4124 Acquired 2024-02-01 Common Stock (4124.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 469 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.